Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 237

Related Citations for PubMed (Select 21957150)

1.

Pyridone 6, a pan-JAK inhibitor, ameliorates allergic skin inflammation of NC/Nga mice via suppression of Th2 and enhancement of Th17.

Nakagawa R, Yoshida H, Asakawa M, Tamiya T, Inoue N, Morita R, Inoue H, Nakao A, Yoshimura A.

J Immunol. 2011 Nov 1;187(9):4611-20. doi: 10.4049/jimmunol.1100649. Epub 2011 Sep 28.

2.

Glucosamine improved atopic dermatitis-like skin lesions in NC/Nga mice by inhibition of Th2 cell development.

Kim CH, Cheong KA, Park CD, Lee AY.

Scand J Immunol. 2011 Jun;73(6):536-45. doi: 10.1111/j.1365-3083.2011.02526.x.

PMID:
21284687
3.

Effects of a Janus kinase inhibitor, pyridone 6, on airway responses in a murine model of asthma.

Matsunaga Y, Inoue H, Fukuyama S, Yoshida H, Moriwaki A, Matsumoto T, Matsumoto K, Asai Y, Kubo M, Yoshimura A, Nakanishi Y.

Biochem Biophys Res Commun. 2011 Jan 7;404(1):261-7. doi: 10.1016/j.bbrc.2010.11.104. Epub 2010 Nov 25.

PMID:
21111712
4.

Administration of poly(I:C) improved dermatophagoides farinae-induced atopic dermatitis-like skin lesions in NC/Nga mice by the regulation of Th1/Th2 balance.

Kim CH, Park CD, Lee AY.

Vaccine. 2012 Mar 23;30(14):2405-10. doi: 10.1016/j.vaccine.2011.11.049. Epub 2011 Nov 23.

PMID:
22119586
5.

Therapeutic effects of combination using glucosamine plus tacrolimus (FK-506) on the development of atopic dermatitis-like skin lesions in NC/Nga mice.

Kim CH, Cheong KA, Park CD, Lee AY.

Scand J Immunol. 2012 May;75(5):471-8. doi: 10.1111/j.1365-3083.2011.02659.x.

PMID:
22023698
6.

Development of atopic dermatitis-like skin lesions in STAT6-deficient NC/Nga mice.

Yagi R, Nagai H, Iigo Y, Akimoto T, Arai T, Kubo M.

J Immunol. 2002 Feb 15;168(4):2020-7.

7.

Oral administration of poly-γ-glutamate ameliorates atopic dermatitis in Nc/Nga mice by suppressing Th2-biased immune response and production of IL-17A.

Lee TY, Kim DJ, Won JN, Lee IH, Sung MH, Poo H.

J Invest Dermatol. 2014 Mar;134(3):704-11. doi: 10.1038/jid.2013.389. Epub 2013 Sep 11.

8.

Lipoteichoic acid-related molecule derived from the streptococcal preparation, OK-432, which suppresses atopic dermatitis-like lesions in NC/Nga mice.

Horiuchi Y, Bae S, Katayama I, Oshikawa T, Okamoto M, Sato M.

Arch Dermatol Res. 2006 Sep;298(4):163-73. Epub 2006 Jul 15.

PMID:
16845523
9.
10.

Low dose CP-690,550 (tofacitinib), a pan-JAK inhibitor, accelerates the onset of experimental autoimmune encephalomyelitis by potentiating Th17 differentiation.

Yoshida H, Kimura A, Fukaya T, Sekiya T, Morita R, Shichita T, Inoue H, Yoshimura A.

Biochem Biophys Res Commun. 2012 Feb 10;418(2):234-40. doi: 10.1016/j.bbrc.2011.12.156. Epub 2012 Jan 9.

PMID:
22252297
11.

Improvement of atopic dermatitis-like skin lesions by Platycodon grandiflorum fermented by Lactobacillus plantarum in NC/Nga mice.

Kim MS, Kim WG, Chung HS, Park BW, Ahn KS, Kim JJ, Bae H.

Biol Pharm Bull. 2012;35(8):1222-9.

12.

Hyperproduction of IFN-gamma by CpG oligodeoxynucleotide-induced exacerbation of atopic dermatitis-like skin lesion in some NC/Nga mice.

Takakura M, Takeshita F, Aihara M, Xin KQ, Ichino M, Okuda K, Ikezawa Z.

J Invest Dermatol. 2005 Dec;125(6):1156-62.

13.

CD4+ T cell depletion changes the cytokine environment from a TH1/TH2 response to a TC17-like response in a murine model of atopic dermatitis.

Christensen GB, Hvid M, Kvist PH, Deleuran B, Deleuran M, Vestergaard C, Kemp K.

Int Immunopharmacol. 2011 Sep;11(9):1285-92. doi: 10.1016/j.intimp.2011.04.010. Epub 2011 Apr 28.

PMID:
21530683
14.

Mechanism underlying the effect of combined therapy using glucosamine and low-dose cyclosporine A on the development of atopic dermatitis-like skin lesions in NC/Nga mice.

Kim CH, Choi YS, Cheong KA, Lee AY.

Int Immunopharmacol. 2013 Feb;15(2):424-32. doi: 10.1016/j.intimp.2013.01.005. Epub 2013 Jan 22.

PMID:
23352844
15.

Therapeutic effects of Baicalein on atopic dermatitis-like skin lesions of NC/Nga mice induced by dermatophagoides pteronyssinus.

Yun MY, Yang JH, Kim DK, Cheong KJ, Song HH, Kim DH, Cheong KJ, Kim YI, Shin SC.

Int Immunopharmacol. 2010 Sep;10(9):1142-8. doi: 10.1016/j.intimp.2010.06.020. Epub 2010 Jul 9.

PMID:
20621172
16.
18.

Hyperresponsive TH2 cells with enhanced nuclear factor-kappa B activation induce atopic dermatitis-like skin lesions in Nishiki-nezumi Cinnamon/Nagoya mice.

Tenda Y, Yamashita M, Kimura MY, Hasegawa A, Shimizu C, Kitajima M, Onodera A, Suzuki A, Seki N, Nakayama T.

J Allergy Clin Immunol. 2006 Sep;118(3):725-33. Epub 2006 Jul 28.

PMID:
16950294
19.

Improvement of atopic dermatitis in NC/Nga mice by topical application of CpG phosphodiester-ODN.

Kim YS, Kim Y, Lee KJ, Kwon HJ, Kim DS, Kim TY.

Int Arch Allergy Immunol. 2007;144(4):315-24. Epub 2007 Jul 11.

PMID:
17671391
20.

Topical application of aloperine improves 2,4-dinitrofluorobenzene-induced atopic dermatitis-like skin lesions in NC/Nga mice.

Yuan XY, Ma HM, Li RZ, Wang RY, Liu W, Guo JY.

Eur J Pharmacol. 2011 May 11;658(2-3):263-9. doi: 10.1016/j.ejphar.2011.02.013. Epub 2011 Mar 1.

PMID:
21371468
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk